Global Compound Paracetamol and Amantadine Hydrochloride Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Compound Paracetamol and Amantadine Hydrochloride Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Pediatric Compound Paracetamol and Amantadine Hydrochloride Tablets
- 1.3.3 Adult Compound Paracetamol and Amantadine Hydrochloride Tablets
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Compound Paracetamol and Amantadine Hydrochloride Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Online Sales
- 1.4.5 Others
- 1.5 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Market Size & Forecast
- 1.5.1 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity (2021-2032)
- 1.5.3 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Sichuan YIKE Pharmaceutical Co., Ltd.
- 2.1.1 Sichuan YIKE Pharmaceutical Co., Ltd. Details
- 2.1.2 Sichuan YIKE Pharmaceutical Co., Ltd. Major Business
- 2.1.3 Sichuan YIKE Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Product and Services
- 2.1.4 Sichuan YIKE Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Sichuan YIKE Pharmaceutical Co., Ltd. Recent Developments/Updates
- 2.2 Jilin Yida Pharmaceutical Co., Ltd.
- 2.2.1 Jilin Yida Pharmaceutical Co., Ltd. Details
- 2.2.2 Jilin Yida Pharmaceutical Co., Ltd. Major Business
- 2.2.3 Jilin Yida Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Product and Services
- 2.2.4 Jilin Yida Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Jilin Yida Pharmaceutical Co., Ltd. Recent Developments/Updates
- 2.3 CSPC Pharmaceutical Group Limited
- 2.3.1 CSPC Pharmaceutical Group Limited Details
- 2.3.2 CSPC Pharmaceutical Group Limited Major Business
- 2.3.3 CSPC Pharmaceutical Group Limited Compound Paracetamol and Amantadine Hydrochloride Tablets Product and Services
- 2.3.4 CSPC Pharmaceutical Group Limited Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 CSPC Pharmaceutical Group Limited Recent Developments/Updates
- 2.4 Inner Mongolia Beiyu Pharmaceutical Co., Ltd.
- 2.4.1 Inner Mongolia Beiyu Pharmaceutical Co., Ltd. Details
- 2.4.2 Inner Mongolia Beiyu Pharmaceutical Co., Ltd. Major Business
- 2.4.3 Inner Mongolia Beiyu Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Product and Services
- 2.4.4 Inner Mongolia Beiyu Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Inner Mongolia Beiyu Pharmaceutical Co., Ltd. Recent Developments/Updates
- 2.5 Zhejiang Shapuaisi Pharmaceutical Co., Ltd.
- 2.5.1 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Details
- 2.5.2 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Major Business
- 2.5.3 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Product and Services
- 2.5.4 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Zhejiang Shapuaisi Pharmaceutical Co., Ltd. Recent Developments/Updates
- 2.6 Sunflower Pharmaceutical Group Co., Ltd.
- 2.6.1 Sunflower Pharmaceutical Group Co., Ltd. Details
- 2.6.2 Sunflower Pharmaceutical Group Co., Ltd. Major Business
- 2.6.3 Sunflower Pharmaceutical Group Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Product and Services
- 2.6.4 Sunflower Pharmaceutical Group Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Sunflower Pharmaceutical Group Co., Ltd. Recent Developments/Updates
- 2.7 Jilin Wutaigankang Pharmaceutical Co., Ltd.
- 2.7.1 Jilin Wutaigankang Pharmaceutical Co., Ltd. Details
- 2.7.2 Jilin Wutaigankang Pharmaceutical Co., Ltd. Major Business
- 2.7.3 Jilin Wutaigankang Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Product and Services
- 2.7.4 Jilin Wutaigankang Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Jilin Wutaigankang Pharmaceutical Co., Ltd. Recent Developments/Updates
- 2.8 Anhui Wansen Pharmaceutical Co., Ltd.
- 2.8.1 Anhui Wansen Pharmaceutical Co., Ltd. Details
- 2.8.2 Anhui Wansen Pharmaceutical Co., Ltd. Major Business
- 2.8.3 Anhui Wansen Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Product and Services
- 2.8.4 Anhui Wansen Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Anhui Wansen Pharmaceutical Co., Ltd. Recent Developments/Updates
- 2.9 Jilin Jian Yisheng Pharmaceutical Co., Ltd.
- 2.9.1 Jilin Jian Yisheng Pharmaceutical Co., Ltd. Details
- 2.9.2 Jilin Jian Yisheng Pharmaceutical Co., Ltd. Major Business
- 2.9.3 Jilin Jian Yisheng Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Product and Services
- 2.9.4 Jilin Jian Yisheng Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Jilin Jian Yisheng Pharmaceutical Co., Ltd. Recent Developments/Updates
- 2.10 Jilin Forte Pharmaceutical Co., Ltd.
- 2.10.1 Jilin Forte Pharmaceutical Co., Ltd. Details
- 2.10.2 Jilin Forte Pharmaceutical Co., Ltd. Major Business
- 2.10.3 Jilin Forte Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Product and Services
- 2.10.4 Jilin Forte Pharmaceutical Co., Ltd. Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Jilin Forte Pharmaceutical Co., Ltd. Recent Developments/Updates
3 Competitive Environment: Compound Paracetamol and Amantadine Hydrochloride Tablets by Manufacturer
- 3.1 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Revenue by Manufacturer (2021-2026)
- 3.3 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Compound Paracetamol and Amantadine Hydrochloride Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Compound Paracetamol and Amantadine Hydrochloride Tablets Manufacturer Market Share in 2025
- 3.4.3 Top 6 Compound Paracetamol and Amantadine Hydrochloride Tablets Manufacturer Market Share in 2025
- 3.5 Compound Paracetamol and Amantadine Hydrochloride Tablets Market: Overall Company Footprint Analysis
- 3.5.1 Compound Paracetamol and Amantadine Hydrochloride Tablets Market: Region Footprint
- 3.5.2 Compound Paracetamol and Amantadine Hydrochloride Tablets Market: Company Product Type Footprint
- 3.5.3 Compound Paracetamol and Amantadine Hydrochloride Tablets Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Market Size by Region
- 4.1.1 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity by Region (2021-2032)
- 4.1.2 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Consumption Value by Region (2021-2032)
- 4.1.3 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Average Price by Region (2021-2032)
- 4.2 North America Compound Paracetamol and Amantadine Hydrochloride Tablets Consumption Value (2021-2032)
- 4.3 Europe Compound Paracetamol and Amantadine Hydrochloride Tablets Consumption Value (2021-2032)
- 4.4 Asia-Pacific Compound Paracetamol and Amantadine Hydrochloride Tablets Consumption Value (2021-2032)
- 4.5 South America Compound Paracetamol and Amantadine Hydrochloride Tablets Consumption Value (2021-2032)
- 4.6 Middle East & Africa Compound Paracetamol and Amantadine Hydrochloride Tablets Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity by Type (2021-2032)
- 5.2 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Consumption Value by Type (2021-2032)
- 5.3 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity by Application (2021-2032)
- 6.2 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Consumption Value by Application (2021-2032)
- 6.3 Global Compound Paracetamol and Amantadine Hydrochloride Tablets Average Price by Application (2021-2032)
7 North America
- 7.1 North America Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity by Type (2021-2032)
- 7.2 North America Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity by Application (2021-2032)
- 7.3 North America Compound Paracetamol and Amantadine Hydrochloride Tablets Market Size by Country
- 7.3.1 North America Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity by Country (2021-2032)
- 7.3.2 North America Compound Paracetamol and Amantadine Hydrochloride Tablets Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity by Type (2021-2032)
- 8.2 Europe Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity by Application (2021-2032)
- 8.3 Europe Compound Paracetamol and Amantadine Hydrochloride Tablets Market Size by Country
- 8.3.1 Europe Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Compound Paracetamol and Amantadine Hydrochloride Tablets Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Compound Paracetamol and Amantadine Hydrochloride Tablets Market Size by Region
- 9.3.1 Asia-Pacific Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Compound Paracetamol and Amantadine Hydrochloride Tablets Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity by Type (2021-2032)
- 10.2 South America Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity by Application (2021-2032)
- 10.3 South America Compound Paracetamol and Amantadine Hydrochloride Tablets Market Size by Country
- 10.3.1 South America Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity by Country (2021-2032)
- 10.3.2 South America Compound Paracetamol and Amantadine Hydrochloride Tablets Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Compound Paracetamol and Amantadine Hydrochloride Tablets Market Size by Country
- 11.3.1 Middle East & Africa Compound Paracetamol and Amantadine Hydrochloride Tablets Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Compound Paracetamol and Amantadine Hydrochloride Tablets Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Compound Paracetamol and Amantadine Hydrochloride Tablets Market Drivers
- 12.2 Compound Paracetamol and Amantadine Hydrochloride Tablets Market Restraints
- 12.3 Compound Paracetamol and Amantadine Hydrochloride Tablets Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Compound Paracetamol and Amantadine Hydrochloride Tablets and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Compound Paracetamol and Amantadine Hydrochloride Tablets
- 13.3 Compound Paracetamol and Amantadine Hydrochloride Tablets Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Compound Paracetamol and Amantadine Hydrochloride Tablets Typical Distributors
- 14.3 Compound Paracetamol and Amantadine Hydrochloride Tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Compound Paracetamol and Amantadine Hydrochloride Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Compound Paracetamol and Amantadine Hydrochloride Tablet is an agent with antipyretic and analgesic effects. It can be used to treat nasal congestion, sore throat, headache, fever, etc. caused by colds. And it has preventive and therapeutic effects on influenza. The main ingredients are acetaminophen, amantadine hydrochloride, chlorpheniramine maleate, artificial bezoar, and caffeine. The auxiliary materials are starch, powdered sugar and magnesium stearate.
This report is a detailed and comprehensive analysis for global Compound Paracetamol and Amantadine Hydrochloride Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Compound Paracetamol and Amantadine Hydrochloride Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Boxes), and average selling prices (US$/Box), 2021-2032
Global Compound Paracetamol and Amantadine Hydrochloride Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Boxes), and average selling prices (US$/Box), 2021-2032
Global Compound Paracetamol and Amantadine Hydrochloride Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Boxes), and average selling prices (US$/Box), 2021-2032
Global Compound Paracetamol and Amantadine Hydrochloride Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Boxes), and ASP (US$/Box), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Compound Paracetamol and Amantadine Hydrochloride Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Compound Paracetamol and Amantadine Hydrochloride Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sichuan YIKE Pharmaceutical Co., Ltd., Jilin Yida Pharmaceutical Co., Ltd., CSPC Pharmaceutical Group Limited, Inner Mongolia Beiyu Pharmaceutical Co., Ltd., Zhejiang Shapuaisi Pharmaceutical Co., Ltd., Sunflower Pharmaceutical Group Co., Ltd., Jilin Wutaigankang Pharmaceutical Co., Ltd., Anhui Wansen Pharmaceutical Co., Ltd., Jilin Jian Yisheng Pharmaceutical Co., Ltd., Jilin Forte Pharmaceutical Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Compound Paracetamol and Amantadine Hydrochloride Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Pediatric Compound Paracetamol and Amantadine Hydrochloride Tablets
Adult Compound Paracetamol and Amantadine Hydrochloride Tablets
Market segment by Application
Hospital
Clinic
Online Sales
Others
Major players covered
Sichuan YIKE Pharmaceutical Co., Ltd.
Jilin Yida Pharmaceutical Co., Ltd.
CSPC Pharmaceutical Group Limited
Inner Mongolia Beiyu Pharmaceutical Co., Ltd.
Zhejiang Shapuaisi Pharmaceutical Co., Ltd.
Sunflower Pharmaceutical Group Co., Ltd.
Jilin Wutaigankang Pharmaceutical Co., Ltd.
Anhui Wansen Pharmaceutical Co., Ltd.
Jilin Jian Yisheng Pharmaceutical Co., Ltd.
Jilin Forte Pharmaceutical Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Compound Paracetamol and Amantadine Hydrochloride Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Compound Paracetamol and Amantadine Hydrochloride Tablets, with price, sales quantity, revenue, and global market share of Compound Paracetamol and Amantadine Hydrochloride Tablets from 2021 to 2026.
Chapter 3, the Compound Paracetamol and Amantadine Hydrochloride Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Compound Paracetamol and Amantadine Hydrochloride Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Compound Paracetamol and Amantadine Hydrochloride Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Compound Paracetamol and Amantadine Hydrochloride Tablets.
Chapter 14 and 15, to describe Compound Paracetamol and Amantadine Hydrochloride Tablets sales channel, distributors, customers, research findings and conclusion.